Navigation Links
Pappas Ventures Names Pat Gage to Scientific Advisory Board
Date:7/9/2012

RESEARCH TRIANGLE PARK, N.C., July 9, 2012 /PRNewswire/ -- Pappas Ventures today announced the appointment of L. Patrick (Pat) Gage, PhD to the company's Scientific Advisory Board (SAB).  Dr. Gage has extensive experience in the biotech and pharmaceutical industry, including previously-held senior positions at Hoffmann-La Roche, Genetics Institute and Wyeth (now Pfizer).  Throughout his career, he oversaw the development of more than a dozen marketed biologics and vaccines, as well as several small molecule drugs.

"We are thrilled to have Pat on our team," said Art Pappas, Managing Partner of Pappas Ventures. "His drug development experience will be invaluable to our portfolio companies and his insight in identifying trends and opportunities in the life sciences industry should further enhance our firm's role as a value-added investor."

During his 18-year career at Hoffmann-La Roche, Dr. Gage held several leadership roles in research management, including service as Vice President of Exploratory Research, which was responsible for U.S. drug discovery. Dr. Gage then joined Genetics Institute, Inc. in 1989 and ultimately served as President after Wyeth (now Pfizer) acquired the company. He was then named President of Wyeth Research, taking responsibility for global pharmaceutical and vaccine R&D, as well as global biopharmaceutical manufacturing.

Dr. Gage founded enGage Biotech Consulting in 2003 to focus on guiding the development of new biopharmaceutical products and companies. In addition to his consulting work, he currently serves as Chairman of Cytokinetics, Inc. and Chairman of Tetraphase Pharmaceuticals.  He previously was Chairman and subsequently Interim CEO of PDL BioPharma, and was Chairman of Adnexus Therapeutics.

"I am delighted to join Pappas Ventures' SAB. The fund's investments mirror my interest in assisting in the development of high-impact pharmaceutical products."

About Pappas Ventures

Founded in 1994, Pappas Ventures invests exclusively in the life sciences sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures. Pappas Ventures has more than $350 million in capital under management, and has guided the launch and/or development of more than 50 companies, including Plexxikon Inc. (acquired by Daiichi Sankyo), Cerexa (acquired by Forest Laboratories), Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Syntonix (acquired by Biogen IDEC), NuVasive (IPO), and Arena Pharmaceuticals (IPO). Most recently, its portfolio company Tesaro conducted a successful initial public offering. For more information about Pappas Ventures and for further information about Pat Gage and the rest of our distinguished Scientific Advisory Board, please visit www.pappasventures.com.

CONTACT: Kimberly Hofman-McEnaney khmcenaney@capstrat.com 919-745-3652


'/>"/>
SOURCE Pappas Ventures
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Files Defamation Lawsuit
2. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
3. DiversityInc Names Lilly a Top Company for Diversity
4. Axis Global Logistics Names Mr. Thomas Brennan, Vice President Strategic Accounts & Life Sciences
5. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
6. myMatrixx Names Craig Rollins, Vice President of Ancillary and Business Development
7. Bausch + Lomb Names John Barr Global President Surgical
8. Forbes Names Pharmalot, a UBM Canon Pharmaceutical Media Group Brand, as a Top Social Media Influencer
9. Wake Forest Baptist Names President of Piedmont Triad Research Park and Chief Innovation Officer
10. EvaluatePharma Names Debbie Paul CEO, Americas to Lead Growth in Key Region
11. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:10/2/2017)... The Rebound mobile app is poised to become a vital ... prescription drug addiction. The app empowers users to develop an ... their dosage in a safe, controlled manner while maximizing well-being. ... 100,000 people to sign up will enjoy 3 months of ... ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... As health ... medicine known as “patient engagement.” The patient is doing more than filling out a ... , “There is an increasing emphasis in health care and research on the ...
(Date:10/13/2017)... ... 2017 , ... PurhealthRX , a leading Health and Nutrition Company, is ... to full spectrum CBD oil will revolutionize the rapidly growing CBD market by reducing ... easily incorporated into liquid products, while reducing costs to end users. , The team ...
(Date:10/13/2017)... ... 13, 2017 , ... Many families have long-term insurance that covers care for ... a waiver for care if the client has a cognitive impairment diagnosis. , ... care, is often waived, so the benefits from their insurance start immediately,” said Mechell ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the Christian history of ... Brink” is the creation of published author, William Nowers. Captain Nowers and his ... veteran, he spent thirty years in the Navy. Following his career as a ...
Breaking Medicine News(10 mins):